772 F.3d 932
1st Cir.2014Background
- Ven-A-Care filed a qui tam False Claims Act (FCA) suit in 1995 alleging drug manufacturers, including Baxter, inflated prices to obtain higher Medicare/Medicaid reimbursements; the operative (fourth amended) complaint was filed in 2002 and kept under seal until 2010.
- After the government declined to intervene, Ven-A-Care settled with Baxter in 2011; the settlement released Baxter for conduct covered by the agreement and Ven-A-Care’s claims were dismissed with the United States’ consent.
- Independently, relators Sun (a former Baxter research director) and Hamilton (an employee of a Baxter customer) filed a qui tam FCA suit against Baxter in 2005, while Ven-A-Care’s complaint remained under seal and thus "pending."
- Sun and Hamilton alleged more detailed, insider facts about Baxter’s pricing and charge‑back practices (including post-2000 conduct), and later challenged the Ven-A-Care settlement as an "alternate remedy" entitling them to a fairness hearing and possible reopening under Rule 60(b).
- Baxter argued Sun and Hamilton’s suit was barred by the FCA’s first-to-file rule (31 U.S.C. § 3730(b)(5)) because Ven-A-Care’s earlier complaint already alleged the essential facts of the same fraudulent pricing scheme; the district court agreed and dismissed Sun and Hamilton’s suit.
- The First Circuit affirmed, holding Ven-A-Care’s complaint provided the “essential facts” sufficient to notify the government and bar the later-filed, more detailed complaint.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether Sun & Hamilton’s FCA suit is barred by the FCA first-to-file rule (§ 3730(b)(5)) | Sun & Hamilton: Ven-A-Care’s complaint was too vague and conclusory as to Baxter; only Sun & Hamilton supplied insiders’ detailed facts necessary to justify their separate suit. | Baxter: Ven-A-Care’s earlier complaint alleged the essential facts of the same pricing/charge‑back fraud and thus precludes related later suits. | Held: Bar applies — Ven-A-Care’s complaint supplied the essential facts and provided sufficient notice to the government; Sun & Hamilton’s suit is barred. |
| Whether greater detail in a later complaint defeats first-to-file bar | Sun & Hamilton: More specific insider details (names, meetings, documents) matter; permitting bar would chill insider whistleblowers. | Baxter: The statute bars later suits based on the same underlying facts even if the later complaint adds detail. | Held: Greater detail does not overcome the bar when the first complaint already states the essential facts. |
| Whether post-2000 conduct alleged by Sun & Hamilton constitutes a distinct fraud | Sun & Hamilton: Post-2000 use of "list sales prices" created a different scheme not covered by Ven-A-Care. | Baxter: Ven-A-Care’s complaint covered the relevant timeframe through 2002 and described the same charge‑back/list-price mechanisms. | Held: Ven-A-Care’s complaint covered post-1999 conduct and provided the essential facts; post-2000 allegations are not a distinct scheme for first-to-file purposes. |
| Whether first-to-file requires Rule 9(b)-level particularity | Sun & Hamilton: Argued heightened particularity should matter. | Baxter: First-to-file is satisfied by essential facts sufficient to notify the government; Rule 9(b) particulars are unnecessary for the bar. | Held: First-to-file requires only essential facts sufficient to permit a meaningful government investigation; Rule 9(b) specificity is not required. |
Key Cases Cited
- United States ex rel. Wilson v. Bristol-Myers Squibb, 750 F.3d 111 (1st Cir. 2014) (establishes first-to-file as jurisdictional in the First Circuit and frames the "essential facts" test)
- United States ex rel. Heineman-Guta v. Guidant Corp., 718 F.3d 28 (1st Cir. 2013) (explains that a first complaint need not meet Rule 9(b) to bar a later suit and articulates "sufficient notice"/"essential facts" standards)
- United States ex rel. Duxbury v. Ortho Biotech Prods., L.P., 579 F.3d 13 (1st Cir. 2009) (distinguishes when later complaint alleges a substantively different scheme and thus survives first-to-file)
- United States ex rel. Branch Consultants v. Allstate Ins. Co., 560 F.3d 371 (5th Cir. 2009) (articulates that once the government knows the essential facts it can discover related frauds)
- United States ex rel. LaCorte v. SmithKline Beecham Clinical Labs., Inc., 149 F.3d 227 (3d Cir. 1998) (describes the value of "genuinely valuable information" in original complaints to satisfy notice for the government)